Hemostemix Inc.
HMTXF
$0.0703
$0.00385.71%
| Weiss Ratings | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.57 | |||
| Price History | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 7.82% | |||
| 30-Day Total Return | -31.75% | |||
| 60-Day Total Return | -57.90% | |||
| 90-Day Total Return | 25.54% | |||
| Year to Date Total Return | -12.13% | |||
| 1-Year Total Return | 55.88% | |||
| 2-Year Total Return | -39.76% | |||
| 3-Year Total Return | -51.28% | |||
| 5-Year Total Return | -28.27% | |||
| 52-Week High % Change | -75.35% | |||
| 52-Week Low % Change | 192.71% | |||
| Price | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.29 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jul 22, 2024 | |||
| 52-Week High Price (Date) | Jan 24, 2025 | |||
| Valuation | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.18M | |||
| Enterprise Value | 13.49M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.02 | |||
| Earnings Per Share Growth | -42.91% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.95 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.07 | |||
| Enterprise Value/EBITDA (TTM) | -13.40 | |||
| Enterprise Value/EBIT | -13.40 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 87.12M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 707-7th Avenue SW Calgary, AB T2P 3H6 | |||
| Website | hemostemix.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -205.74% | |||
| Return on Equity | -- | |||
| Income Statement | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -1.05M | |||
| EBIT (TTM) | -1.05M | |||
| Net Income (TTM) | -1.47M | |||
| Net Income Avl. to Common (TTM) | -1.47M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -20.23% | |||
| EPS Diluted (TTM) | -0.02 | |||
| EPS Diluted Growth (Q YOY) | -13.04% | |||
| Balance Sheet | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 46.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 117.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -6.42M | |||
| Current Ratio (Q) | 0.044 | |||
| Book Value Per Share (Q) | -$0.07 | |||
| Total Assets (Q) | 117.20K | |||
| Total Current Liabilities (Q) | 2.64M | |||
| Total Debt (Q) | 3.53M | |||
| Total Liabilities (Q) | 6.53M | |||
| Total Common Equity (Q) | -6.42M | |||
| Cash Flow | HMTXF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 13.50K | |||
| Net Change in Cash (TTM) | -232.00K | |||
| Levered Free Cash Flow (TTM) | -107.40K | |||
| Cash from Operations (TTM) | -245.50K | |||
